FOGLIETTA, MYRIAM
 Distribuzione geografica
Continente #
NA - Nord America 1.807
EU - Europa 1.343
AS - Asia 490
AF - Africa 37
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 3
Totale 3.702
Nazione #
US - Stati Uniti d'America 1.785
CN - Cina 380
DE - Germania 217
IT - Italia 190
AT - Austria 181
SE - Svezia 167
IE - Irlanda 159
UA - Ucraina 109
FR - Francia 100
FI - Finlandia 76
KR - Corea 44
GB - Regno Unito 35
PL - Polonia 35
SN - Senegal 31
VN - Vietnam 31
CA - Canada 21
NL - Olanda 21
RU - Federazione Russa 14
AU - Australia 13
BE - Belgio 11
JP - Giappone 10
BY - Bielorussia 8
EU - Europa 8
IN - India 7
ES - Italia 6
UZ - Uzbekistan 6
HK - Hong Kong 5
GR - Grecia 4
CH - Svizzera 3
ZA - Sudafrica 3
RO - Romania 2
TW - Taiwan 2
A1 - Anonimo 1
BW - Botswana 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SG - Singapore 1
TR - Turchia 1
UY - Uruguay 1
Totale 3.702
Città #
Chandler 304
Beijing 281
Vienna 180
Dublin 158
Fairfield 112
Houston 96
Jacksonville 94
Nyköping 80
Dearborn 79
Ann Arbor 69
Torino 67
Villeurbanne 62
Medford 58
Wilmington 49
Woodbridge 49
Princeton 46
Ashburn 42
Fremont 42
Cambridge 38
San Mateo 35
Seattle 33
Warsaw 30
Pisa 28
Washington 27
Redwood City 18
Phoenix 17
Toronto 17
Milan 14
Turin 14
Dong Ket 13
Mountain View 12
Nürnberg 12
Brussels 11
Guangzhou 9
Düsseldorf 8
Hefei 8
Norwalk 8
Boardman 7
Boston 7
Nanjing 7
San Jose 7
Shanghai 7
Changsha 6
Kunming 6
Rotterdam 6
Adelaide 5
Chengdu 5
Liverpool 5
Munich 5
Nanchang 5
Tokyo 5
Dronten 4
Hangzhou 4
Jinan 4
San Diego 4
Central District 3
Heidelberg 3
Johannesburg 3
Limoges 3
Philadelphia 3
Provo 3
Tianjin 3
Wuhan 3
Zhengzhou 3
Bucharest 2
Buscate 2
Central 2
Costa Mesa 2
Curcuris 2
Deiva Marina 2
Den Haag 2
Erlangen 2
Fuzhou 2
Genoa 2
Groningen 2
Hanover 2
Kharkiv 2
Los Corrales de Buelna 2
Melbourne 2
Nanning 2
New Haven 2
Nichelino 2
Ottawa 2
Palermo 2
Paris 2
Pittsburgh 2
Quzhou 2
Québec 2
Raritan 2
Retamar 2
Romainville 2
Rome 2
Southend 2
Taipei 2
Upper Marlboro 2
Wroclaw 2
Aalburg 1
Ain Youcef 1
Arkesden 1
Athens 1
Totale 2.414
Nome #
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells 261
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells 237
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. 189
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma 180
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells 149
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 124
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 114
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL) 111
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression 110
Vγ9Vδ2 T cells as strategic weapons to improve the potency of immune checkpoint blockade and immune interventions in human myeloma 110
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells 98
Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma 96
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 94
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 94
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy 93
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 87
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) 86
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespective of the disease status. 78
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma 73
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells 72
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma 72
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells 72
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. 72
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID 70
Distribution of γδ T cells in patients with hematological malignancies 70
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions 68
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. 68
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 68
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity upon short-term incubation with zoledronic acid 67
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method 67
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 67
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients. 66
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells 64
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 64
The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells 63
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 57
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: Diagnostic challenges and therapeutic options: Two case reports 57
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 55
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. 54
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 53
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases 39
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma 37
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. 32
Totale 3.858
Categoria #
all - tutte 8.103
article - articoli 0
book - libri 0
conference - conferenze 3.645
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019406 0 0 21 11 31 16 37 73 24 53 77 63
2019/2020523 15 15 19 55 27 105 81 38 32 67 32 37
2020/2021501 44 49 29 11 70 18 27 30 44 33 81 65
2021/2022624 31 5 11 39 18 9 107 34 14 79 175 102
2022/2023835 83 84 21 85 72 190 56 54 89 27 46 28
2023/2024151 36 77 38 0 0 0 0 0 0 0 0 0
Totale 3.858